Meller Stephan, Lauerma Antti I, Kopp Frank Michael, Winterberg Franziska, Anthoni Minna, Müller Anja, Gombert Michael, Haahtela Anna, Alenius Harri, Rieker Juliane, Dieu-Nosjean Marie-Caroline, Kubitza Robert Christof, Gleichmann Ernst, Ruzicka Thomas, Zlotnik Albert, Homey Bernhard
Department of Dermatology, Heinrich-Heine-University, Düsseldorf, Germany.
J Allergy Clin Immunol. 2007 Jun;119(6):1470-80. doi: 10.1016/j.jaci.2006.12.654. Epub 2007 Mar 2.
As clinical and histological features of allergic and irritant contact dermatitis share common characteristics, the differentiation between them in the preclinical and clinical evaluations of chemicals remains difficult.
To identify the differences in the underlying immunological mechanisms of chemical-induced allergic or irritant skin responses.
We systematically studied the involvement of chemokines in both diseases by quantitative real-time polymerase chain reaction in mice and humans. The cellular origin of relevant chemokines and receptors was determined using immunohistochemistry; functional relevance was demonstrated in vitro by transwell chemotaxis and in vivo by adoptive transfer experiments using a model of hapten-induced murine contact hypersensitivity.
Independent of overall skin inflammation, chemical-induced allergic and irritant skin responses showed distinct molecular expression profiles. In particular, chemokine genes predominantly regulated by T-cell effector cytokines demonstrated differential upregulation in hapten-specific skin inflammation. Notably, the expression of CXCR3 ligands, such as CXCL9 (Mig) and CXCL10 (IP-10), was upregulated in chemical-induced allergic skin responses when compared with irritant skin responses. Furthermore, we showed that inflammatory chemokines such as CXCL10 prime leukocytes to respond to CXCL12 (SDF-1), increasing their recruitment both in vitro and in vivo.
We provide important insights into the molecular basis of chemical-induced allergic and irritant contact dermatitis, identify novel markers suitable for their differentiation, and demonstrate the cooperation of inflammatory and homeostatic chemokines in the recruitment of pathogenic leukocyte subsets.
Molecular differences between both diseases represent the basis for new approaches to diagnostics and therapy.
由于过敏性和刺激性接触性皮炎的临床及组织学特征具有共同特点,因此在化学品的临床前和临床评估中区分这两种皮炎仍然困难。
确定化学物质诱导的过敏性或刺激性皮肤反应潜在免疫机制的差异。
我们通过对小鼠和人类进行定量实时聚合酶链反应,系统研究趋化因子在这两种疾病中的作用。使用免疫组织化学确定相关趋化因子和受体的细胞来源;通过Transwell趋化实验在体外证明其功能相关性,并在体内通过使用半抗原诱导的小鼠接触性超敏反应模型进行过继转移实验来证明。
与整体皮肤炎症无关,化学物质诱导的过敏性和刺激性皮肤反应显示出不同的分子表达谱。特别是,主要由T细胞效应细胞因子调节的趋化因子基因在半抗原特异性皮肤炎症中表现出不同程度的上调。值得注意的是,与刺激性皮肤反应相比,CXCR3配体如CXCL9(Mig)和CXCL10(IP-10)的表达在化学物质诱导的过敏性皮肤反应中上调。此外,我们表明炎症趋化因子如CXCL10使白细胞对CXCL12(SDF-1)产生反应,从而在体外和体内增加其募集。
我们为化学物质诱导的过敏性和刺激性接触性皮炎的分子基础提供了重要见解,鉴定了适合区分它们的新标志物,并证明了炎症趋化因子和稳态趋化因子在致病性白细胞亚群募集中的协同作用。
这两种疾病之间的分子差异代表了诊断和治疗新方法的基础。